Review

Digital twins in personalized medicine: Insights from a systematic review

Volume: 11 Number: 5 September 4, 2025
EN

Digital twins in personalized medicine: Insights from a systematic review

Abstract

Objectives: Digital twins (DTs) are increasingly recognized as valuable tools in the advancement of personalized medicine (PM).

Methods: This systematic review explores the current landscape of DT applications across medical domains, focusing on their feasibility, benefits, challenges, and potential future roles. Following PRISMA guidelines, literature was sourced from PubMed and Scopus using clearly defined inclusion and exclusion criteria, resulting in 14 studies eligible for full-text review.

Results: Findings show that DTs are being utilized in various specialties such as cardiology, geriatrics, radiology, and oncology, offering advantages in cost reduction, treatment precision, and patient outcomes. However, key challenges remain, including data privacy, technical integration, ethical considerations, and the need for interdisciplinary collaboration.

Conclusions: This systematic review offers a comprehensive synthesis of how DTs are being integrated into PM and highlights areas requiring further empirical research to support wider implementation.

Keywords

Ethical Statement

As this study is a systematic review, ethical committee approval is not required. There are no human or animal elements in our study. Data were obtained from open sources on the internet.

References

  1. 1. Yuan B. What Personalized Medicine Humans Need and Way to It --also on the Practical Significance and Scientific Limitations of Precision Medicine. Pharmgenomics Pers Med. 2022;15:927-942. doi: 10.2147/PGPM.S380767.
  2. 2. Mishra V, Chanda P, Tambuwala MM, Suttee A. Personalized medicine: An overview. Int J Pharm Qual Assur. 2019;10(2):290-294. doi: 10.25258/ijpqa.10.2.13
  3. 3. Pritchard DE, Moeckel F, Villa MS, Housman LT, McCarty CA, McLeod HL. Strategies for integrating personalized medicine into healthcare practice. Per Med. 2017 ;14(2):141-152. doi: 10.2217/pme-2016-0064.
  4. 4. Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res. 2009;154(6):277-287. doi: 10.1016/j.trsl.2009.09.005.
  5. 5. Calcaterra V, Pagani V, Zuccotti G. Digital Twin: A Future Health Challenge in Prevention, Early Diagnosis and Personalisation of Medical Care in Paediatrics. Int J Environ Res Public Health. 2023;20(3):2181. doi: 10.3390/ijerph20032181.
  6. 6. Geissler F, Heiß R, Kopp M, et al. Personalized computed tomography - Automated estimation of height and weight of a simulated digital twin using a 3D camera and artificial intelligence. Rofo. 2021;193(4):437-445. doi: 10.1055/a-1253-8558.
  7. 7. Shamanna P, Dharmalingam M, Sahay R, et al. Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program. Sci Rep. 2021;11(1):14892. doi: 10.1038/s41598-021-94339-6.
  8. 8. de Sio FS, Faber NS, Savulescu J, Vincent NA. Why less praise for enhanced performance? Moving beyond responsibility-shifting, authenticity, and cheating toward a natu re-of-activities approach. In: Jotterand F, Dubljevic V, editors. Cognitive Enhancement: Ethical and Policy Implications in International Perspectives. New York: Oxford Academic. 2016. pp. 27-41.

Details

Primary Language

English

Subjects

Primary Health Care

Journal Section

Review

Early Pub Date

July 28, 2025

Publication Date

September 4, 2025

Submission Date

March 19, 2025

Acceptance Date

July 21, 2025

Published in Issue

Year 2025 Volume: 11 Number: 5

AMA
1.Uğraş E. Digital twins in personalized medicine: Insights from a systematic review. Eur Res J. 2025;11(5):1015-1022. doi:10.18621/eurj.1661091